All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark

Authors:

Abstract
No abstract available
Funding Information
  • Aarhus Universitets Forskningsfond
  • Novo Nordisk
  • Novo Nordisk Fonden
  • Sundhed og Sygdom, Det Frie Forskningsråd

This publication has 19 references indexed in Scilit: